An Update on Aspirin for Cardioprevention: Implications for Patient Care

Christopher P Cannon

doi:10.12788/jfp.0143

An Update on Aspirin for Cardioprevention: Implications for Patient Care

J Fam Pract. 2021 Jan-Feb;70(1 suppl [i]):S1-S10. doi: 10.12788/jfp.0143.

Author

Christopher P Cannon¹

Affiliation

¹ Harvard Medical School, Cardiovascular Innovation, Cardiovascular Division, Brigham and Women's Faulkner Hospital, Boston, MA.

PMID: 33752228
DOI: 10.12788/jfp.0143

Abstract

The goal of this activity is to increase awareness among healthcare providers about the role of aspirin in the primary and secondary prevention of cardiovascular disease.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Aspirin / therapeutic use*
Cardiovascular Diseases / prevention & control*
Humans
Platelet Aggregation Inhibitors / therapeutic use*
Primary Prevention / methods*
Secondary Prevention / methods*
Stroke / prevention & control

Substances

Platelet Aggregation Inhibitors
Aspirin